Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ja Hye Myung"'
Autor:
Seungpyo Hong, Andrew Z. Wang, Bhishamjit S. Chera, Joel E. Tepper, Tian Zhang, Ronald C. Chen, Colette Shen, Seth M. Miller, Kevin A. Tam, Kyle Wang, Michael J. Poellmann, Sin-Jung Park, Joseph M. Caster, Michael J. Eblan, Ja Hye Myung
Table S1. Clinical and demographic characteristics of recruited cancer patients; Table S2. Demographic characteristics of recruited healthy donors; Figure S1. Reproducibility confirmation of CapioCyte-D by testing duplicated blood samples from three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591a3bcf4b77ce40fa1a6fed30f1d1b3
https://doi.org/10.1158/1078-0432.22464156.v1
https://doi.org/10.1158/1078-0432.22464156.v1
Autor:
Ashley S. Cha, Kevin A. Tam, Seungpyo Hong, Ja Hye Myung, Roohollah Sharifi, Gina Votta-Velis, Alain Borgeat, Robert E. Molokie, Michael J. Poellmann
Publikováno v:
Analytical Chemistry. 91:8374-8382
Detection of circulating tumor cells (CTCs) relying on their expression of epithelial cell markers, such as epithelial cell adhesion molecule (EpCAM), has been commonly used. However, this approach unlikely captures CTCs that have undergone the proce
Autor:
Helena L. Palka-Hamblin, Karen J. Colley, Hao Jui Hsu, Michael Cheong, Seungpyo Hong, Gaurang P. Bhide, Ja Hye Myung
Publikováno v:
Analytical Chemistry. 90:3670-3675
Enumeration of circulating tumor cells (CTCs) of small-cell lung cancer (SCLC) patients has been shown to predict the disease progress and long-term survival. Most CTC detection methods rely on epithelial surface markers, such as epithelial cell adhe
Publikováno v:
Advanced Drug Delivery Reviews. 125:36-47
Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizin
Publikováno v:
Current Topics in Medicinal Chemistry. 17:1542-1554
Dendritic nanomaterials have attracted a great deal of scientific interest due to their high capacity for multifunctionalization and potential in various biomedical applications, such as drug/gene delivery and diagnostic systems. Depending on the mol
Autor:
Ja Hye, Myung, Ashley, Cha, Kevin A, Tam, Michael, Poellmann, Alain, Borgeat, Roohollah, Sharifi, Robert E, Molokie, Gina, Votta-Velis, Seungpyo, Hong
Publikováno v:
Anal Chem
Detection of circulating tumor cells (CTCs) relying on their expression of epithelial cell markers, such as epithelial cell adhesion molecule (EpCAM), has been commonly used. However, this approach unlikely captures CTCs that have undergone the proce
Autor:
Peter Petrochenko, Seongkyu Yoon, Alexander Nivorozhkin, Ken Avery, Darby Kozak, Benjamin Rivnay, Nelson Landrau, Ja Hye Myung, Joseph Wakim
Publikováno v:
International journal of pharmaceutics. 565
Identifying the critical process parameters (CPPs) of a complex drug product manufacture and the associated impact on critical quality attributes (CQAs) is essential to the development and quality control of both new and generic drugs. AmBisome, a li
Publikováno v:
WIREs Nanomedicine and Nanobiotechnology. 8:223-239
Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection m
Autor:
Kevin A. Tam, Michael J. Eblan, Seungpyo Hong, Joel E. Tepper, Kyle Wang, Seth M. Miller, Michael J. Poellmann, Joseph M. Caster, Andrew Andrew Wang, Sin jung Park, Ronald C. Chen, Ja Hye Myung, Bhishamjit S. Chera, Colette J. Shen, Tian Zhang
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(11)
Purpose: We aimed to examine the effects of multivalent binding and biomimetic cell rolling on the sensitivity and specificity of circulating tumor cell (CTC) capture. We also investigated the clinical significance of CTCs and their kinetic profiles
Autor:
Pan Tong, Pamela Villalobos, Ethan Dmitrovsky, Sarah J. Freemantle, Carmen Behrens, Barbara Mino, J. Jack Lee, Lin Zheng, Ignacio I. Wistuba, John V. Heymach, Xi Liu, Jing Wang, Jaime Rodriguez-Canales, Seungpyo Hong, Jason Roszik, Ja Hye Myung, Lisa Maria Mustachio, Faye M. Johnson, Masanori Kawakami, Shanhu Hu
Publikováno v:
Journal of the National Cancer Institute. 109(6)
Background The first generation CDK2/7/9 inhibitor seliciclib (CYC202) causes multipolar anaphase and apoptosis in lung cancer cells with supernumerary centrosomes (known as anaphase catastrophe). We investigated a new and potent CDK2/9 inhibitor, CC